0001209191-20-018736.txt : 20200313 0001209191-20-018736.hdr.sgml : 20200313 20200313121945 ACCESSION NUMBER: 0001209191-20-018736 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Auchincloss Thomas G CENTRAL INDEX KEY: 0001377820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36310 FILM NUMBER: 20711556 MAIL ADDRESS: STREET 1: C/O METABOLIX, INC. STREET 2: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001367920 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-860-0045 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: SUITE 3000N CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060628 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001367920 CONCERT PHARMACEUTICALS, INC. CNCE 0001377820 Auchincloss Thomas G C/O CONCERT PHARMACEUTICALS, INC. 65 HAYDEN AVENUE, SUITE 3000N LEXINGTON MA 02421 1 0 0 0 Common Stock 2020-03-12 4 P 0 1500 8.515 A 6500 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.50 to $8.547, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. /s/ Nancy Stuart as attorney-in-fact for Thomas G. Auchincloss 2020-03-13